|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.990 USD | +0.34% |
|
+2.57% | -43.97% |
| 08-28 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-14 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 300M 258M 242M 221M 414M 28.35B 415M 2.88B 1.11B 14.52B 1.13B 1.1B 46.25B | P/E 2026 * |
-10.7x | P/E 2027 * | -13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 300M 258M 242M 221M 414M 28.35B 415M 2.88B 1.11B 14.52B 1.13B 1.1B 46.25B | EV / Sales 2026 * |
20.2x | EV / Sales 2027 * | 15.1x |
| Free-Float |
67.96% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript : CapsoVision, Inc.
| 1 day | +0.34% | ||
| 1 week | +2.57% | ||
| Current month | +2.57% | ||
| 1 month | -15.63% | ||
| 3 months | -16.69% | ||
| 6 months | +16.99% | ||
| Current year | -43.97% |
| 1 week | 5.83 |  | 6.09 |
| 1 month | 5.75 | | 7 |
| Current year | 4.5 | | 11.37 |
| 1 year | 3.5 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 01/11/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 01/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 01/11/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 01/01/2025 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 01/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Director | 61,068 | 0.1225% | ||
| 08/07/26 | Buy | Director | 81,300 | 0.1631% | ||
| 01/07/26 | Free | Director | 1,710 | 0.0034% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | +2.57% | +67.32% | - | 300M | |
| -1.23% | +2.62% | -24.82% | +0.41% | 13.06B | |
| +3.57% | -4.75% | +14.55% | +19.89% | 4.38B | |
| +3.07% | +4.89% | -35.60% | -51.23% | 1.31B | |
| -1.10% | -2.62% | -37.11% | -40.52% | 1.13B | |
| -3.63% | -3.39% | +15.92% | +76.32% | 1.07B | |
| +1.26% | +1.72% | - | - | 1.05B | |
| +0.44% | -3.71% | -36.93% | - | 1.03B | |
| +3.52% | -2.89% | +30.09% | +105.28% | 521M | |
| -0.28% | -3.53% | -68.64% | +281.94% | 244M | |
| Average | +0.60% | -1.04% | -8.36% | +56.01% | 2.41B | |
| Weighted average by Cap. | +0.09% | +0.22% | -15.22% | +8.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 12.79M 12.03M 10.98M 20.54M 1.41B 20.6M 143M 55.13M 720M 55.85M 54.63M 2.29B | 19.82M 17.05M 16.03M 14.64M 27.37M 1.87B 27.46M 190M 73.48M 960M 74.44M 72.81M 3.06B |
| Net income | -27.56M -23.7M -22.29M -20.35M -38.05M -2.61B -38.17M -264M -102M -1.33B -103M -101M -4.25B | -22.1M -19.01M -17.88M -16.32M -30.52M -2.09B -30.62M -212M -81.93M -1.07B -82.99M -81.18M -3.41B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $5.990 | +0.34% | 38,501 |
| 03/09/26 | $5.970 | +0.67% | 62,720 |
| 02/09/26 | $5.930 | +1.02% | 58,639 |
| 01/09/26 | $5.870 | +0.51% | 62,215 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.990USD
Average target price
9.500USD
Spread / Average Target
+58.60%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
